罗格列酮对糖尿病兔肾小管上皮细胞表型转化与NADPH氧化酶的影响  

Effect of Rosiglitazone on the phenotypic transformation of renal tubular epithelial cells and NADPH oxidase of diabetic rabbits

在线阅读下载全文

作  者:罗莉[1] 杨立勇[2] 许昌声 

机构地区:[1]福建医科大学附属第一医院干部病房,福建福州350005 [2]福建医科大学附属第一医院内分泌科,福建福州350005 [3]福建省高血压研究所,福建福州350005

出  处:《中国医药导报》2009年第35期30-31,33,共3页China Medical Herald

摘  要:目的:研究罗格列酮对NADPH氧化酶表达的影响,探讨其对肾小管上皮细胞表型转化(EMT)的可能作用机制。方法:取28只新西兰大白兔,随机分为对照组(NC组)、糖尿病组(DM组)和罗格列酮干预组(RGT组),DM组和RGT组以四氧嘧啶耳缘静脉注射,RGT组每天给予罗格列酮1.0mg/kg灌胃。第16周末时测定各组血糖、血脂、肌酐清除率(Ccr)、超氧化物歧化酶(SOD);免疫组织化学检测α-平滑肌肌动蛋白(α-SMA),Western印迹检测NADPH氧化酶亚基p22phox的蛋白表达。结果:与NC组比较,DM组Ccr明显升高(P<0.01),SOD明显降低(P<0.05);p22phox和α-SMA蛋白表达升高;与DM组比较,RGT组p22phox和α-SMA蛋白表达降低(P<0.05),而其他指标也有改善。结论:RGT可能通过抑制糖尿病兔肾脏NADPH氧化酶活性,减少肾内氧化应激,阻断α-SMA表达,从而抑制EMT。Objective: To study the effect of Rosiglitazone (RGT) on the expression of NADPH oxidase, and explore the possible mechanism of it on the phenotypic transformation of renal tubular epithelial cells. Methods: 28 New Zealand white rabbits were selected and randomly divided into three groups: NC group, DM group and RGT group, the DM group and RGT group were injected with alloxan via ear vein, and RGT group was given 1.0 mg/kg RGT for intragastric administration once a day. At the end of 16 week, the blood glucose, blood fat, Ccr and SOD of each group were determined, α-SMA was detected by immunohistochemistry, and the protein expression of the subunit p22^phox of NADPH oxidase was detected by Western blot. Results: The Ccr of DM group was significantly higher and the SOD was lower than those of the NC group (P〈0.01, P〈0.05), and the protein expressions of p22^phox and α-SMA were increased. The protein expressions of p22^phox and α-SMA were lower than those of the DM group (P〈0.05), and other indexes were also improved. Conclusion: RGT probably inhibits EMT by inhibiting the activity of kidney NADPH oxidase of diabetic rabbits, decreasing the oxidative stress in kidney and further blocking the expression of α-SMA.

关 键 词:罗格列酮 糖尿病兔 肾小管上皮细胞表型转化 NADPH氧化酶 

分 类 号:R-332[医药卫生]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象